美股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

Apogee Therapeutics

81.16

-1.2700-1.54%

盘后：81.160.00000.00%16:10 EDT

成交量：33.84万

成交额：2,766.08万

市值：61.15亿

市盈率：-18.78

高：84.12

开：82.43

低：81.03

收：82.43

52周最高：95.32

52周最低：34.34

股本：7,533.99万

流通股本：7,030.80万

量比：0.47

换手率：0.48%

股息：- -

股息率：- -

每股收益(TTM):-4.3206

每股收益(LYR):-4.2155

净资产收益率：-28.47%

总资产收益率：-19.01%

市净率：4.87

市盈率(LYR):-19.25

数据加载中...

总览公司新闻资讯公告

Apogee Therapeutics完成公开募股，承销商全额行使超额配售权，募集资金总额达4.03亿美元

BUZZ-Apogee Therapeutics 3.5 亿美元股票出售后恢复攀升

Apogee Therapeutics公布3.5亿美元承销公开发行定价

美国研究综述-Apogee Therapeutics、Insmed、Sunoco

BUZZ-Apogee Therapeutics 宣布计划出售 3 亿美元股票后下跌

Apogee Therapeutics盘中飙升16.6% 公司宣布湿疹药物中期试验展现持久疗效

BUZZ-Apogee 因湿疹药物在中期试验中带来持久疗效而跃升

Apogee Therapeutics：3个月与6个月剂量治疗下病灶及瘙痒指标反应持续深化

Apogee Therapeutics公布Zumilokibart（APG777）II期试验52周积极数据，显示中重度特应性皮炎患者每3个月及6个月给药可维持并加深疗效

Apogee Therapeutics公司——APEX B部分16周诱导研究结果预计2026年第二季度公布，三期临床试验将于2026年下半年启动

Apogee Therapeutics公司——Zumilokibart耐受性良好，安全性与同类药物一致

2026年最有价值的管线资产排名

BUZZ--美国股票走势-Shake Shack、Arrowhead 制药公司、洛克希德马丁公司

BUZZ--美国股票走势-Alkermes、Ball Corp、NovaBridge

BUZZ--美国股票走势-英特尔、Vistra、杰克逊金融公司

BUZZ-Apogee Therapeutics 因哮喘药物在早期试验中显示出前景而上涨

Apogee Therapeutics公布潜在同类最佳抗IL-13抗体Zumilokibart（APG777）治疗轻中度哮喘患者的1B期试验积极中期结果，并展望2026年里程碑与前景

Apogee Therapeutics将于2026年1月6日召开电话会议公布Apg777针对轻中度哮喘患者的1B期临床试验中期结果及2026年预期里程碑

BUZZ-加拿大皇家银行称生物技术行业反弹势头强劲，2026 年商机无限

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/APGE/news"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"APGE","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"APGE\",,,,,undefined,":{"symbol":"APGE","market":"US","secType":"STK","nameCN":"Apogee Therapeutics","latestPrice":81.16,"timestamp":1779480000000,"preClose":82.43,"halted":0,"volume":338435,"hourTrading":{"tag":"盘后","latestPrice":81.16,"preClose":81.16,"latestTime":"16:10 EDT","volume":8353,"amount":677929.48,"timestamp":1779480604856,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.015407012010190587,"floatShares":70308023,"shares":75339900,"eps":-4.320623,"marketStatus":"休市中","change":-1.27,"latestTime":"05-22 16:00:00 EDT","open":82.43,"high":84.12,"low":81.03,"amount":27660753,"amplitude":0.037486,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-4.320623,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1779782400000},"marketStatusCode":7,"adr":0,"listingDate":1689307200000,"exchange":"NASDAQ","adjPreClose":82.43,"preHourTrading":{"tag":"盘前","latestPrice":82.42,"preClose":82.43,"latestTime":"09:29 EDT","volume":10,"amount":819.75006,"timestamp":1779456541090,"change":-0.01,"changeRate":-0.000121,"amplitude":0.011282},"postHourTrading":{"tag":"盘后","latestPrice":81.16,"preClose":81.16,"latestTime":"16:10 EDT","volume":8353,"amount":677929.48,"timestamp":1779480604856,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.47318199598750776,"impliedVol":0.653,"impliedVolPercentile":0.4502},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"APGE\",,,,,undefined,":{"symbol":"APGE","floatShares":70308023,"roa":"-19.01%","roe":"-28.47%","lyrEps":-4.215513,"volumeRatio":0.47318199598750776,"shares":75339900,"dividePrice":0,"high":84.12,"amplitude":0.037486,"preClose":82.43,"low":81.03,"week52Low":34.34,"pbRate":"4.87","week52High":95.315,"institutionHeld":0,"latestPrice":81.16,"eps":-4.320623,"divideRate":0,"volume":338435,"delay":0,"ttmEps":-4.320623,"open":82.43,"prevYearClose":75.48,"prevWeekClose":81.14,"prevMonthClose":82.89,"prevQuarterClose":84.17,"fiveDayClose":81.14,"twentyDayClose":85.61,"sixtyDayClose":69.09},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/APGE\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-05-11","symbol":"APGE","fiscalQuarterEnding":"2026/03","expectedEps":-1.12,"name":null,"time":"盘前","type":"earning","dateTimestamp":1778472000000,"reportTimeType":"pre","actualEps":-1.06},{"market":"US","date":"2026-03-02","symbol":"APGE","fiscalQuarterEnding":"2025/12","expectedEps":-1.05,"name":null,"time":"盘前","type":"earning","dateTimestamp":1772427600000,"reportTimeType":"pre","actualEps":-1.03},{"market":"US","date":"2025-11-10","symbol":"APGE","fiscalQuarterEnding":"2025/09","expectedEps":-1.14,"name":null,"time":"盘前","type":"earning","dateTimestamp":1762750800000,"reportTimeType":"pre","actualEps":-1.11},{"market":"US","date":"2025-08-11","symbol":"APGE","fiscalQuarterEnding":"2025/06","expectedEps":-1.03,"name":null,"time":"盘前","type":"earning","dateTimestamp":1754884800000,"reportTimeType":"pre","actualEps":-1.13},{"market":"US","date":"2025-05-12","symbol":"APGE","fiscalQuarterEnding":"2025/03","expectedEps":-1.19,"name":null,"time":"盘前","type":"earning","dateTimestamp":1747022400000,"reportTimeType":"pre","actualEps":-0.95}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"APGE\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"APGE\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.4444,"buy":0.3889,"hold":0.1667,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.3889,"analysts":18,"updateTime":1777694400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/APGE\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"APGE","date":"2026-05-22","current":-18.784328,"percent":0.325648,"low":-42.099968,"twenty":-25.109359,"median":-18.46514,"eighty":-12.275404,"high":-8.51736,"avg":-19.409066,"sd":7.377952,"marketCap":6177967349},"quantilePoints":[{"date":"2023-07-14","current":-14.120082,"twenty":-14.120082,"median":-14.120082,"eighty":-14.120082,"marketCap":728904256},{"date":"2023-07-21","current":-18.011929,"twenty":-18.356106,"median":-18.157543,"eighty":-18.011929,"marketCap":929808491},{"date":"2023-07-28","current":-20.899222,"twenty":-20.280785,"median":-18.735584,"eighty":-18.04723,"marketCap":1078855761},{"date":"2023-08-04","current":-20.732342,"twenty":-20.732342,"median":-20.114656,"eighty":-18.267856,"marketCap":1070241131},{"date":"2023-08-11","current":-21.547107,"twenty":-20.865853,"median":-20.262175,"eighty":-18.356106,"marketCap":1112300797},{"date":"2023-08-18","current":-23.166822,"twenty":-21.272247,"median":-20.482022,"eighty":-18.735584,"marketCap":1195913385},{"date":"2023-08-25","current":-24.246631,"twenty":-22.764347,"median":-20.836643,"eighty":-19.947026,"marketCap":1251655111},{"date":"2023-09-01","current":-16.923199,"twenty":-22.901778,"median":-20.784492,"eighty":-18.356106,"marketCap":1162468350},{"date":"2023-09-08","current":-17.424846,"twenty":-22.791833,"median":-20.482022,"eighty":-18.04017,"marketCap":1196926871},{"date":"2023-09-15","current":-15.33711,"twenty":-22.261745,"median":-20.262175,"eighty":-17.454355,"marketCap":1053518613},{"date":"2023-09-22","current":-15.742854,"twenty":-21.87694,"median":-20.07464,"eighty":-16.946806,"marketCap":1081389476},{"date":"2023-09-29","current":-15.255962,"twenty":-21.600116,"median":-18.735584,"eighty":-16.181057,"marketCap":1047944441},{"date":"2023-10-06","current":-15.816626,"twenty":-21.327219,"median":-18.248406,"eighty":-15.736952,"marketCap":1086456906},{"date":"2023-10-13","current":-14.754315,"twenty":-21.232981,"median":-18.011929,"eighty":-15.43744,"marketCap":1013485920},{"date":"2023-10-20","current":-14.732183,"twenty":-21.097514,"median":-17.509684,"eighty":-15.343012,"marketCap":1011965691},{"date":"2023-10-27","current":-11.065736,"twenty":-21.032725,"median":-17.443289,"eighty":-15.295798,"marketCap":760114440},{"date":"2023-11-03","current":-13.714136,"twenty":-20.892548,"median":-17.107628,"eighty":-15.064155,"marketCap":942035162},{"date":"2023-11-10","current":-11.751812,"twenty":-20.860011,"median":-16.901067,"eighty":-14.764643,"marketCap":807241535},{"date":"2023-11-17","current":-12.191046,"twenty":-20.815783,"median":-16.340404,"eighty":-14.242502,"marketCap":851834915},{"date":"2023-11-24","current":-12.473884,"twenty":-20.732342,"median":-15.9863,"eighty":-13.271633,"marketCap":871597891},{"date":"2023-12-01","current":-14.149156,"twenty":-20.643994,"median":-15.77974,"eighty":-12.959786,"marketCap":988655514},{"date":"2023-12-08","current":-15.76641,"twenty":-20.320051,"median":-15.713345,"eighty":-13.06857,"marketCap":1101659195},{"date":"2023-12-15","current":-16.854248,"twenty":-20.280785,"median":-15.705968,"eighty":-13.227243,"marketCap":1177670639},{"date":"2023-12-22","current":-18.52952,"twenty":-20.262175,"median":-15.76641,"eighty":-13.271633,"marketCap":1294728262},{"date":"2023-12-29","current":-21.77128,"twenty":-20.316166,"median":-15.824003,"eighty":-13.537135,"marketCap":1521242365},{"date":"2024-01-05","current":-20.48763,"twenty":-20.454114,"median":-15.9863,"eighty":-13.786432,"marketCap":1431548862},{"date":"2024-01-12","current":-23.098443,"twenty":-20.721111,"median":-16.285075,"eighty":-14.084509,"marketCap":1613976327},{"date":"2024-01-19","current":-23.34502,"twenty":-20.899222,"median":-16.57141,"eighty":-14.120082,"marketCap":1631205588},{"date":"2024-01-26","current":-26.1734,"twenty":-21.423171,"median":-16.854248,"eighty":-14.149156,"marketCap":1828835342},{"date":"2024-02-02","current":-24.650426,"twenty":-22.136094,"median":-16.901067,"eighty":-14.410237,"marketCap":1722419321},{"date":"2024-02-09","current":-26.833356,"twenty":-22.901778,"median":-17.107628,"eighty":-14.722084,"marketCap":1874948952},{"date":"2024-02-16","current":-25.919571,"twenty":-23.170966,"median":-17.443289,"eighty":-14.732183,"marketCap":1811099339},{"date":"2024-02-23","current":-25.462679,"twenty":-23.458155,"median":-17.594521,"eighty":-14.738085,"marketCap":1779174532},{"date":"2024-03-01","current":-25.252364,"twenty":-23.903055,"median":-18.011929,"eighty":-14.745463,"marketCap":1764478986},{"date":"2024-03-08","current":-39.349598,"twenty":-24.476372,"median":-18.248406,"eighty":-14.75284,"marketCap":3304775976},{"date":"2024-03-15","current":-39.31944,"twenty":-25.034796,"median":-18.52952,"eighty":-14.795627,"marketCap":3302243192},{"date":"2024-03-22","current":-40.133695,"twenty":-25.237859,"median":-19.967125,"eighty":-14.977105,"marketCap":3370628348},{"date":"2024-03-28","current":-41.080642,"twenty":-25.310382,"median":-20.039026,"eighty":-15.024319,"marketCap":3450157751},{"date":"2024-04-05","current":-35.585933,"twenty":-25.583066,"median":-20.203754,"eighty":-15.040549,"marketCap":2988684589},{"date":"2024-04-12","current":-40.39061,"twenty":-25.977589,"median":-20.297181,"eighty":-15.087984,"marketCap":3392205375},{"date":"2024-04-19","current":-33.647243,"twenty":-26.134238,"median":-20.48763,"eighty":-15.119386,"marketCap":2825863713},{"date":"2024-04-26","current":-30.802638,"twenty":-26.87687,"median":-20.704265,"eighty":-15.154157,"marketCap":2586959527},{"date":"2024-05-03","current":-35.061005,"twenty":-31.417884,"median":-20.865853,"eighty":-15.223502,"marketCap":2944598502},{"date":"2024-05-10","current":-35.544605,"twenty":-33.702281,"median":-21.144633,"eighty":-15.273667,"marketCap":2985213654},{"date":"2024-05-17","current":-30.341768,"twenty":-33.2059,"median":-21.423171,"eighty":-15.316454,"marketCap":3142011451},{"date":"2024-05-24","current":-25.989488,"twenty":-32.751748,"median":-21.791716,"eighty":-15.341537,"marketCap":2691315483},{"date":"2024-05-31","current":-26.170128,"twenty":-32.249341,"median":-22.218395,"eighty":-15.347905,"marketCap":2710021411},{"date":"2024-06-07","current":-23.773834,"twenty":-31.497141,"median":-22.764347,"eighty":-15.361417,"marketCap":2461875577},{"date":"2024-06-14","current":-24.341154,"twenty":-31.168024,"median":-22.917136,"eighty":-15.378422,"marketCap":2520623884},{"date":"2024-06-21","current":-21.479149,"twenty":-30.802638,"median":-22.901778,"eighty":-15.396128,"marketCap":2224251827},{"date":"2024-06-28","current":-22.551696,"twenty":-30.67474,"median":-22.901778,"eighty":-15.416784,"marketCap":2335318278},{"date":"2024-07-05","current":-21.168675,"twenty":-30.454668,"median":-22.551696,"eighty":-15.452028,"marketCap":2192101012},{"date":"2024-07-12","current":-25.927394,"twenty":-30.290963,"median":-22.599678,"eighty":-15.490824,"marketCap":2684885320},{"date":"2024-07-15","current":-27.107194,"twenty":-30.240158,"median":-22.64766,"eighty":-15.512581,"marketCap":2807058416},{"date":"2024-08-02","current":-25.825784,"twenty":-30.189354,"median":-22.706004,"eighty":-15.534337,"marketCap":2674363235},{"date":"2024-08-09","current":-22.78314,"twenty":-29.894686,"median":-22.901778,"eighty":-15.586554,"marketCap":2359285249},{"date":"2024-08-16","current":-22.360657,"twenty":-29.660984,"median":-22.773744,"eighty":-15.598555,"marketCap":2649402436},{"date":"2024-08-23","current":-23.604561,"twenty":-29.231009,"median":-22.862169,"eighty":-15.66023,"marketCap":2796786413},{"date":"2024-08-30","current":-24.399278,"twenty":-28.636347,"median":-22.994085,"eighty":-15.707443,"marketCap":2890948398},{"date":"2024-09-06","current":-23.811878,"twenty":-28.151516,"median":-23.098851,"eighty":-15.725149,"marketCap":2821350409},{"date":"2024-09-13","current":-24.28081,"twenty":-27.512504,"median":-23.170966,"eighty":-15.752276,"marketCap":2876911828},{"date":"2024-09-20","current":-26.136794,"twenty":-27.110581,"median":-23.268758,"eighty":-15.786496,"marketCap":3096818079},{"date":"2024-09-27","current":-28.649283,"twenty":-28.484417,"median":-23.34502,"eighty":-15.822528,"marketCap":3394510318},{"date":"2024-10-04","current":-28.061884,"twenty":-28.569318,"median":-23.434542,"eighty":-15.893348,"marketCap":3324912329},{"date":"2024-10-11","current":-26.610663,"twenty":-28.484417,"median":-23.533922,"eighty":-16.011479,"marketCap":3152964356},{"date":"2024-10-18","current":-27.755844,"twenty":-28.448831,"median":-23.612583,"eighty":-16.121447,"marketCap":3288651192},{"date":"2024-10-25","current":-25.643182,"twenty":-28.355515,"median":-23.773834,"eighty":-16.274009,"marketCap":3038332374},{"date":"2024-10-31","current":-27.099339,"twenty":-28.252419,"median":-23.811878,"eighty":-16.385155,"marketCap":3210865204},{"date":"2024-11-08","current":-28.654219,"twenty":-28.465143,"median":-23.860074,"eighty":-16.567059,"marketCap":3395095175},{"date":"2024-11-15","current":-19.789128,"twenty":-28.485404,"median":-23.853973,"eighty":-16.630879,"marketCap":2902332924},{"date":"2024-11-22","current":-16.628998,"twenty":-28.465143,"median":-23.803477,"eighty":-16.671147,"marketCap":2438858722},{"date":"2024-11-29","current":-17.517481,"twenty":-28.399895,"median":-23.76973,"eighty":-16.839744,"marketCap":2569166386},{"date":"2024-12-06","current":-18.297329,"twenty":-28.288946,"median":-23.604561,"eighty":-16.854248,"marketCap":2683541235},{"date":"2024-12-13","current":-17.195455,"twenty":-28.106309,"median":-23.497667,"eighty":-16.861788,"marketCap":2521936971},{"date":"2024-12-20","current":-18.243012,"twenty":-28.061884,"median":-23.417542,"eighty":-16.878936,"marketCap":2675574828},{"date":"2024-12-27","current":-18.305089,"twenty":-28.042139,"median":-23.34502,"eighty":-16.878936,"marketCap":2684679293},{"date":"2025-01-03","current":-18.29345,"twenty":-27.898004,"median":-23.314068,"eighty":-16.905494,"marketCap":2682972206},{"date":"2025-01-10","current":-19.092697,"twenty":-27.799282,"median":-23.175118,"eighty":-16.935003,"marketCap":2800192201},{"date":"2025-01-17","current":-14.239016,"twenty":-27.785817,"median":-23.13304,"eighty":-16.857264,"marketCap":2088336797},{"date":"2025-01-24","current":-15.60084,"twenty":-27.774326,"median":-23.084739,"eighty":-16.58873,"marketCap":2288066011},{"date":"2025-01-31","current":-16.489324,"twenty":-27.755844,"median":-22.901778,"eighty":-16.251878,"marketCap":2418373675},{"date":"2025-02-07","current":-16.155657,"twenty":-27.743997,"median":-22.822654,"eighty":-16.03771,"marketCap":2369437172},{"date":"2025-02-14","current":-14.068303,"twenty":-27.666994,"median":-22.64766,"eighty":-15.83959,"marketCap":2063299516},{"date":"2025-02-21","current":-13.17206,"twenty":-27.548527,"median":-22.532767,"eighty":-15.742854,"marketCap":1931853794},{"date":"2025-02-28","current":-11.845154,"twenty":-27.262231,"median":-22.345048,"eighty":-15.697836,"marketCap":1737245842},{"date":"2025-03-07","current":-11.30201,"twenty":-27.112839,"median":-22.212997,"eighty":-15.60472,"marketCap":2058615932},{"date":"2025-03-14","current":-12.223647,"twenty":-27.107194,"median":-21.977899,"eighty":-15.577851,"marketCap":2226488393},{"date":"2025-03-21","current":-12.874214,"twenty":-27.104275,"median":-21.832491,"eighty":-15.410728,"marketCap":2344986602},{"date":"2025-03-28","current":-12.51704,"twenty":-27.099339,"median":-21.774807,"eighty":-15.344488,"marketCap":2279928762},{"date":"2025-04-04","current":-11.158503,"twenty":-27.089467,"median":-21.479149,"eighty":-15.267174,"marketCap":2032476621},{"date":"2025-04-11","current":-9.54803,"twenty":-27.02252,"median":-21.347709,"eighty":-15.123173,"marketCap":1739135468},{"date":"2025-04-17","current":-10.217731,"twenty":-27.018004,"median":-21.19592,"eighty":-15.044975,"marketCap":1861118918},{"date":"2025-04-25","current":-11.815448,"twenty":-27.009303,"median":-21.066101,"eighty":-14.75284,"marketCap":2152136576},{"date":"2025-05-02","current":-12.501095,"twenty":-26.955194,"median":-20.851248,"eighty":-14.659715,"marketCap":2277024394},{"date":"2025-05-09","current":-12.057816,"twenty":-26.905994,"median":-20.676189,"eighty":-14.171382,"marketCap":2196282968},{"date":"2025-05-16","current":-11.538128,"twenty":-26.893009,"median":-20.509211,"eighty":-14.009329,"marketCap":2369827680},{"date":"2025-05-23","current":-11.469666,"twenty":-26.845089,"median":-20.320051,"eighty":-13.400194,"marketCap":2355766140},{"date":"2025-05-30","current":-10.709474,"twenty":-26.800437,"median":-20.280785,"eighty":-13.20517,"marketCap":2199629509},{"date":"2025-06-06","current":-10.699527,"twenty":-26.74614,"median":-20.193343,"eighty":-12.998374,"marketCap":2197586600},{"date":"2025-06-13","current":-11.895942,"twenty":-26.656227,"median":-20.052494,"eighty":-12.887608,"marketCap":2443319391},{"date":"2025-06-20","current":-11.702697,"twenty":-26.554695,"median":-19.987224,"eighty":-12.832982,"marketCap":2403628584},{"date":"2025-06-27","current":-12.450101,"twenty":-26.451682,"median":-19.588347,"eighty":-12.738391,"marketCap":2557138617},{"date":"2025-07-03","current":-13.487372,"twenty":-26.404333,"median":-19.162534,"eighty":-12.723904,"marketCap":2770184861},{"date":"2025-07-11","current":-10.960977,"twenty":-26.318444,"median":-18.921984,"eighty":-12.668332,"marketCap":2251285927},{"date":"2025-07-18","current":-11.083176,"twenty":-26.254685,"median":-18.735668,"eighty":-12.572137,"marketCap":2276384526},{"date":"2025-07-25","current":-11.833421,"twenty":-26.172746,"median":-18.534,"eighty":-12.51704,"marketCap":2430478247},{"date":"2025-08-01","current":-10.872879,"twenty":-26.165436,"median":-18.435064,"eighty":-12.454858,"marketCap":2233191588},{"date":"2025-08-08","current":-10.230624,"twenty":-26.144692,"median":-18.356106,"eighty":-12.348931,"marketCap":2101278024},{"date":"2025-08-15","current":-9.370325,"twenty":-26.131061,"median":-18.310909,"eighty":-12.239332,"marketCap":2227054492},{"date":"2025-08-22","current":-8.957767,"twenty":-26.099427,"median":-18.29345,"eighty":-12.125473,"marketCap":2129001470},{"date":"2025-08-29","current":-9.024303,"twenty":-26.061716,"median":-18.235984,"eighty":-12.057962,"marketCap":2144815236},{"date":"2025-09-05","current":-9.149983,"twenty":-26.050112,"median":-18.048125,"eighty":-11.971712,"marketCap":2174685683},{"date":"2025-09-12","current":-9.184484,"twenty":-25.999346,"median":-17.978348,"eighty":-11.914309,"marketCap":2182885414},{"date":"2025-09-19","current":-9.470344,"twenty":-25.989488,"median":-17.837569,"eighty":-11.833421,"marketCap":2250826038},{"date":"2025-09-26","current":-9.246091,"twenty":-25.963085,"median":-17.587319,"eighty":-11.751667,"marketCap":2197527790},{"date":"2025-10-03","current":-9.761132,"twenty":-25.927394,"median":-17.537558,"eighty":-11.64586,"marketCap":2319938053},{"date":"2025-10-10","current":-13.112594,"twenty":-25.927394,"median":-17.474803,"eighty":-11.60039,"marketCap":3116483307},{"date":"2025-10-17","current":-14.719201,"twenty":-25.919571,"median":-17.381927,"eighty":-11.6264,"marketCap":3498327236},{"date":"2025-10-24","current":-14.83497,"twenty":-25.825784,"median":-17.31961,"eighty":-11.641401,"marketCap":3525842169},{"date":"2025-10-31","current":-15.446892,"twenty":-25.767274,"median":-17.151542,"eighty":-11.64586,"marketCap":3671278245},{"date":"2025-11-07","current":-15.158848,"twenty":-25.763689,"median":-17.013102,"eighty":-11.649617,"marketCap":3602818471},{"date":"2025-11-14","current":-16.75274,"twenty":-25.752769,"median":-16.901067,"eighty":-11.702697,"marketCap":4249734472},{"date":"2025-11-21","current":-16.859157,"twenty":-25.643182,"median":-16.952708,"eighty":-11.751008,"marketCap":4276729768},{"date":"2025-11-28","current":-19.147128,"twenty":-25.58,"median":-17.00282,"eighty":-11.751535,"marketCap":4857128632},{"date":"2025-12-05","current":-20.086261,"twenty":-25.516057,"median":-17.081704,"eighty":-11.751783,"marketCap":5095362120},{"date":"2025-12-12","current":-20.360285,"twenty":-25.476749,"median":-17.24758,"eighty":-11.795704,"marketCap":5164875007},{"date":"2025-12-19","current":-20.578441,"twenty":-25.464129,"median":-17.327965,"eighty":-11.813694,"marketCap":5220215364},{"date":"2025-12-26","current":-20.775313,"twenty":-25.437705,"median":-17.381927,"eighty":-11.826232,"marketCap":5270156661},{"date":"2026-01-02","current":-20.08094,"twenty":-25.407235,"median":-17.443781,"eighty":-11.835695,"marketCap":5094012355},{"date":"2026-01-09","current":-20.613026,"twenty":-25.376631,"median":-17.517481,"eighty":-11.841525,"marketCap":5228988835},{"date":"2026-01-16","current":-21.482988,"twenty":-25.344147,"median":-17.566657,"eighty":-11.865469,"marketCap":5449675380},{"date":"2026-01-23","current":-21.246209,"twenty":-25.316184,"median":-17.607671,"eighty":-11.899615,"marketCap":5389610846},{"date":"2026-01-30","current":-18.617702,"twenty":-25.310382,"median":-17.773551,"eighty":-11.916319,"marketCap":4722827035},{"date":"2026-02-06","current":-16.529263,"twenty":-25.299938,"median":-17.629714,"eighty":-11.92777,"marketCap":4193044351},{"date":"2026-02-13","current":-18.439453,"twenty":-25.257004,"median":-17.587319,"eighty":-11.943328,"marketCap":4677609914},{"date":"2026-02-20","current":-18.338357,"twenty":-25.252364,"median":-17.631406,"eighty":-11.950995,"marketCap":4651964383},{"date":"2026-02-27","current":-18.380924,"twenty":-25.237859,"median":-17.924865,"eighty":-11.971712,"marketCap":4662762501},{"date":"2026-03-06","current":-19.084656,"twenty":-25.237859,"median":-18.011929,"eighty":-12.048249,"marketCap":4882675550},{"date":"2026-03-13","current":-19.781628,"twenty":-25.201598,"median":-18.048125,"eighty":-12.051438,"marketCap":5060990972},{"date":"2026-03-20","current":-18.433431,"twenty":-25.17554,"median":-18.05103,"eighty":-12.057816,"marketCap":4716064230},{"date":"2026-03-27","current":-22.635495,"twenty":-25.092814,"median":-18.211825,"eighty":-12.058545,"marketCap":5791132948},{"date":"2026-04-02","current":-24.315405,"twenty":-25.034796,"median":-18.255434,"eighty":-12.060324,"marketCap":6220926288},{"date":"2026-04-10","current":-24.973515,"twenty":-25.014384,"median":-18.297329,"eighty":-12.063509,"marketCap":6389298937},{"date":"2026-04-17","current":-26.136752,"twenty":-25.109359,"median":-18.322222,"eighty":-12.100103,"marketCap":6686904979},{"date":"2026-04-24","current":-25.484415,"twenty":-25.24076,"median":-18.338357,"eighty":-12.174653,"marketCap":6520009283},{"date":"2026-05-01","current":-23.925736,"twenty":-25.237859,"median":-18.357757,"eighty":-12.211865,"marketCap":6121231957},{"date":"2026-05-08","current":-23.887288,"twenty":-25.20885,"median":-18.380924,"eighty":-12.222332,"marketCap":6111395326},{"date":"2026-05-15","current":-22.900754,"twenty":-25.180752,"median":-18.433431,"eighty":-12.226576,"marketCap":6288890455},{"date":"2026-05-22","current":-22.496831,"twenty":-25.109359,"median":-18.46514,"eighty":-12.275404,"marketCap":6177967349}],"updateTime":1779551623338},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"APGE\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1184384981","title":"Apogee Therapeutics完成公开募股，承销商全额行使超额配售权，募集资金总额达4.03亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1184384981","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1184384981?lang=zh_cn&edition=fundamental","pubTime":"2026-03-27 04:03","pubTimestamp":1774555392,"startTime":"0","endTime":"0","summary":"生物制药公司Apogee Therapeutics, Inc.近日宣布，其公开发行项目已正式完成，承销商全额行使了超额配售选择权，额外购入公司股份。本次发行累计募集资金总额高达4.03亿美元。\n此次公开募股的成功，不仅彰显了市场对Apogee Therapeutics研发前景的信心，也为公司后续的药物研发与临床推进提供了充足的资金保障。公司表示，所募资金将主要用于推进其在研管线项目的开发，并支持企业日常运营及潜在的战略合作机会。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","APGE","LU0053671581.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622074259","title":"BUZZ-Apogee Therapeutics 3.5 亿美元股票出售后恢复攀升","url":"https://stock-news.laohu8.com/highlight/detail?id=2622074259","media":"路透中文","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622074259?lang=zh_cn&edition=fundamental","pubTime":"2026-03-25 22:15","pubTimestamp":1774448129,"startTime":"0","endTime":"0","summary":"3月25日 - ** Apogee Therapeutics APGE.O在完成 3.5 亿美元的后续发行后，周三早盘股价上涨 13.3%，报 82.68 美元。** 周二，APGE 的股价下跌了近 8%，此前该公司在令人鼓舞的湿疹药物数据公布后，发起了 3 亿美元的股票发行 。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"37684715aaf54a73b9fe52ee56a263cc","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260325:nL4S40D1F5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["APGE","BK4127","BK4139","JEF","BK4559","LU0053671581.USD","SF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1157135932","title":"Apogee Therapeutics公布3.5亿美元承销公开发行定价","url":"https://stock-news.laohu8.com/highlight/detail?id=1157135932","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1157135932?lang=zh_cn&edition=fundamental","pubTime":"2026-03-25 09:55","pubTimestamp":1774403756,"startTime":"0","endTime":"0","summary":"旧金山和波士顿，2026年3月24日——临床阶段生物技术公司Apogee Therapeutics, Inc.今日宣布，其先前公布的承销公开发行已完成定价。此次发行以每股70.00美元的公开发行价格，共计发行5,000,000股普通股。在扣除承销折扣、佣金以及Apogee应承担的其他发行费用之前，公司预计从此次发行中获得的总收益约为3.5亿美元。此外，Apogee已授予承销商一项为期30天的选择权，允许其以公开发行价额外购买最多750,000股普通股。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["USA","APGE","BK4132","AD","BK4139","LU0053671581.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621048051","title":"美国研究综述-Apogee Therapeutics、Insmed、Sunoco","url":"https://stock-news.laohu8.com/highlight/detail?id=2621048051","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621048051?lang=zh_cn&edition=fundamental","pubTime":"2026-03-24 15:39","pubTimestamp":1774337964,"startTime":"0","endTime":"0","summary":"美国研究综述-Apogee Therapeutics、Insmed、Sunoco路透3月24日 - 华尔街证券分析师周二调整了对几家美国上市公司的评级和目标价，其中包括 Apogee Therapeutics、Insmed 和 Sunoco。要闻 * Apogee Therapeutics Inc APGE.O：Stephens 将目标价从 100 美元上调至 110 美元* Insmed Inc INSM.O：Leerink Partners将目标价从210美元上调至215美元* Sunoco LP SUN.N：摩根大通将目标价从66美元上调至73美元以下是路透周二报道的美国公司研究行动摘要。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"37684715aaf54a73b9fe52ee56a263cc","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260324:nL4S40C0IN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1721429402.USD","BK4212","LU1571399168.USD","LU1803068623.USD","ADM","BK4138","LU2380233275.USD","DAR","BK4597","LU0320765992.SGD","LU2360106947.USD","LU0251131958.USD","LU1721429741.USD","LU0471298777.SGD","LW","LU0012050646.USD","LU0889565916.HKD","LU0256331488.USD","APGE","LU2211817866.USD","BK4588","BK4189","LU1878469433.USD","BG","LU0053671581.USD","INSM","LU0385154629.USD","BK4139","LU0471298694.HKD","LU0048573561.USD","BK4585","LU0106261612.USD","LU0251142724.SGD","LU2308191902.HKD","LU0742534661.SGD","BK4590","SUN","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621808439","title":"BUZZ-Apogee Therapeutics 宣布计划出售 3 亿美元股票后下跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2621808439","media":"路透中文","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621808439?lang=zh_cn&edition=fundamental","pubTime":"2026-03-24 04:19","pubTimestamp":1774297183,"startTime":"0","endTime":"0","summary":"3月23日 - ** Apogee Therapeutics APGE.O股价在延时交易中下跌 1.2%，至 78.281 美元，原因是该公司寻求股票融资** 总部位于马萨诸塞州沃尔瑟姆的APGE开始发行3亿美元的股票， 。(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"37684715aaf54a73b9fe52ee56a263cc","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260323:nL4S40B1TW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4559","BK4127","JEF","LU0053671581.USD","APGE","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1115413918","title":"Apogee Therapeutics盘中飙升16.6% 公司宣布湿疹药物中期试验展现持久疗效","url":"https://stock-news.laohu8.com/highlight/detail?id=1115413918","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1115413918?lang=zh_cn&edition=fundamental","pubTime":"2026-03-23 18:51","pubTimestamp":1774263071,"startTime":"0","endTime":"0","summary":"Apogee Therapeutics公司股价在盘前交易中大幅上涨16.6%，此前该公司宣布其湿疹治疗药物在中期临床试验中展现出持久的疗效。这一积极数据点燃了投资者对这款创新疗法的期待，市场反应热烈。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","APGE","LU0053671581.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621177735","title":"BUZZ-Apogee 因湿疹药物在中期试验中带来持久疗效而跃升","url":"https://stock-news.laohu8.com/highlight/detail?id=2621177735","media":"路透中文","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621177735?lang=zh_cn&edition=fundamental","pubTime":"2026-03-23 18:47","pubTimestamp":1774262852,"startTime":"0","endTime":"0","summary":"BUZZ-Apogee 因湿疹药物在中期试验中带来持久疗效而跃升3月23日 - ** 生物技术公司Apogee Therapeutics APGE.O股价盘前上涨22%至81美元** 该公司称其试验性湿疹药物zumilokibart对中重度特应性皮炎患者有持久疗效，特应性皮炎是一种慢性皮肤病，会引起皮疹瘙痒** 在一项中期试验中，75%的患者每三个月服药一次，85%的患者每六个月服药一次，52周时疾病严重程度至少改善了75%。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"37684715aaf54a73b9fe52ee56a263cc","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260323:nL4T40B0WA:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0053671581.USD","APGE","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1167148054","title":"Apogee Therapeutics：3个月与6个月剂量治疗下病灶及瘙痒指标反应持续深化","url":"https://stock-news.laohu8.com/highlight/detail?id=1167148054","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1167148054?lang=zh_cn&edition=fundamental","pubTime":"2026-03-23 18:34","pubTimestamp":1774262099,"startTime":"0","endTime":"0","summary":"Apogee Therapeutics宣布，其临床研究数据显示，在3个月和6个月的给药周期后，患者病灶改善程度与瘙痒控制指标均呈现持续深化趋势。这一进展凸显了长期治疗对疾病关键症状的累积增效作用。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["APGE","LU0053671581.USD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1192197415","title":"Apogee Therapeutics公布Zumilokibart（APG777）II期试验52周积极数据，显示中重度特应性皮炎患者每3个月及6个月给药可维持并加深疗效","url":"https://stock-news.laohu8.com/highlight/detail?id=1192197415","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1192197415?lang=zh_cn&edition=fundamental","pubTime":"2026-03-23 18:33","pubTimestamp":1774262037,"startTime":"0","endTime":"0","summary":"Apogee Therapeutics（股票代码：APGE）近日宣布，其候选药物Zumilokibart（APG777）在治疗中重度特应性皮炎的II期临床试验中，获得了52周的积极数据。研究结果表明，无论是每3个月还是每6个月一次的给药方案，均能有效维持并持续加深患者的临床应答，展现出持久的疗效潜力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["APGE","BK4139","LU0053671581.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1194423233","title":"Apogee Therapeutics公司——APEX B部分16周诱导研究结果预计2026年第二季度公布，三期临床试验将于2026年下半年启动","url":"https://stock-news.laohu8.com/highlight/detail?id=1194423233","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1194423233?lang=zh_cn&edition=fundamental","pubTime":"2026-03-23 18:33","pubTimestamp":1774261990,"startTime":"0","endTime":"0","summary":"Apogee Therapeutics公司宣布，其APEX研究B部分针对16周诱导期的数据结果预计在2026年第二季度揭晓。紧随其后，公司计划于2026年下半年正式启动三期临床试验。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LU0053671581.USD","APGE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1166710296","title":"Apogee Therapeutics公司——Zumilokibart耐受性良好，安全性与同类药物一致","url":"https://stock-news.laohu8.com/highlight/detail?id=1166710296","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1166710296?lang=zh_cn&edition=fundamental","pubTime":"2026-03-23 18:32","pubTimestamp":1774261967,"startTime":"0","endTime":"0","summary":"Apogee Therapeutics公司宣布，其研发的Zumilokibart在临床试验中表现出良好的耐受性，且安全性特征与同类药物保持一致。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LU0053671581.USD","APGE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2606279517","title":"2026年最有价值的管线资产排名","url":"https://stock-news.laohu8.com/highlight/detail?id=2606279517","media":"药智网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606279517?lang=zh_cn&edition=fundamental","pubTime":"2026-01-27 10:37","pubTimestamp":1769481473,"startTime":"0","endTime":"0","summary":"通过对医药开发管线进行系统性的NPV排名，能够以前瞻性的财务视角剖析各大药企的战略底牌。当前处于III期，2026年将公布多项顶线数据。临床推进节奏已经很清晰：诺和公开计划在2026年第一季度启动口服与皮下制剂的III期项目。2026年的临床读数将直接决定这条机制路线能否兑现“更安全抗凝”的差异化主张。公司披露的给药方案为每周皮下注射600 mg，最长治疗52周。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260127104114a6b0efbc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260127104114a6b0efbc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NVO","BK4605","LLY","BMY","IE00BZ1G4Q59.USD","BK4588","JNJ","LU1861215975.USD","LU1861214812.USD","LU1093756168.USD","ROIV","LU1861220033.SGD","AMGN","LU1854103824.USD","BK4007","BK4585","LU0154236417.USD","IE00BZ199S13.USD","LU1720051108.HKD","LU0124384867.USD","BK4141","04332","BK4512","LU1854104046.USD","LU2298322129.HKD","LU2360107325.USD","LU0348723411.USD","LU1548497426.USD","LU1978683503.SGD","LU0724618433.USD","IE00BFMHRM44.USD","LU1861219969.SGD","LU1720051017.SGD","BK4599","RVMD","LU1093756325.SGD","RHHBY","IE00BD6J9T35.USD","BK4532","IE00BKVL7J92.USD","IMVT","LU2357305700.SGD","APGE"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2601819819","title":"BUZZ--美国股票走势-Shake Shack、Arrowhead 制药公司、洛克希德马丁公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2601819819","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601819819?lang=zh_cn&edition=fundamental","pubTime":"2026-01-06 23:52","pubTimestamp":1767714728,"startTime":"0","endTime":"0","summary":".N美国东部时间10:30，道琼斯工业平均指数.DJI上涨0.42%，报49,184.92点。标普 500 指数.SPX上涨 0.42%，报 6,931.22 点；纳斯达克综合指数.IXIC上涨 0.49%，报 23,508.79 点。。nL4N3Y70PF ** CoreWeave Inc CRWV.O:BUZZ - 因 Truist 开始报道而获得 \"持有 \"评级；股价","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260106:nL4S3Y710Z:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TFC","SHAK","VST","ALMS","BALL","PNC","EPAM","CORZ","AEVA","ACN","CDE","ALKS","NBP","BK","IMSR","ACRS","DLR","STT","O","GNPX","ALB","INTU","NEM","IFF","LMT","CRNX","APGE","GL","STAA","MCHP","OS","EQIX","REGN","NTRS","VRTX","FERG","JXN","HL","ZETA","UAA","AIG","BAC","ANGO","GILD","CFG"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2601818061","title":"BUZZ--美国股票走势-Alkermes、Ball Corp、NovaBridge","url":"https://stock-news.laohu8.com/highlight/detail?id=2601818061","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601818061?lang=zh_cn&edition=fundamental","pubTime":"2026-01-06 22:12","pubTimestamp":1767708747,"startTime":"0","endTime":"0","summary":".N** 国际香精香料公司IFF.N：BUZZ - MS看好配料领域的 \"结构性赢家\"，减持帝斯曼股票，增持吉娃丹股票。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260106:nL4T3Y70VL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MCHP","ZETA","UAA","GILD","OS","ALMS","STT","RTO.UK","NVDU","HGT.UK","ALKS","JXN","CDE","NVDS","NVD","NBP","ANGO","NVDX","3NVD.UK","CRNX","AU","NVDS.UK","O","ALB","APGE","VRTX","ACN","AIG","BALL","GL","NEM","IFF","REGN","ACRS","AEVA","VST","INTU","BK","FERG","HL","NTRS","VERX","2NVD.UK","NVDY","GNPX"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2601689428","title":"BUZZ--美国股票走势-英特尔、Vistra、杰克逊金融公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2601689428","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601689428?lang=zh_cn&edition=fundamental","pubTime":"2026-01-06 20:17","pubTimestamp":1767701860,"startTime":"0","endTime":"0","summary":"nL6N3Y70NP ** Crinetics Pharmaceuticals Inc CRNX.O:BUZZ - 在宣布发行 3.5 亿美元股票后微跌   nL6N3Y70NV ** Albemarle Corp ALB.N:BUZZ - 贝伦贝格上调对 Albemarle 的预测值   nL6N3Y70LZ ** 杰克逊金融公司JXN.N:BUZZ - 在TPG投资5亿美元后上涨   nL6N3Y70NS (为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260106:nL4T3Y70QX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0005OL40V9.USD","NVD3.UK","LU2023251221.USD","VST","CDE","NVDS","LU1232071149.USD","LU2097344431.USD","LU0225283273.USD","ZETA","IFF","LU0210536198.USD","NVDS.UK","AEVA","FERG","NVDU","SNVD.UK","SG9999015358.SGD","2NVD.UK","NVIW.SI","JXN","INTC","NVDD","LU1974910355.USD","HL","LU2360106780.USD","LU0943347566.SGD","NVD","OS","LU2237957811.SGD","NVD2.UK","HGT.UK","RTO.UK","MCHP","LU1145028129.USD","ALB","3NVD.UK","LU0683600562.USD","ANGO","NVDX","LU0210528500.USD","LU1487256676.USD","CRNX","UAA","NVDY","APGE","IE00BJLML261.HKD","LU0708994859.HKD"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2601899776","title":"BUZZ-Apogee Therapeutics 因哮喘药物在早期试验中显示出前景而上涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2601899776","media":"路透中文","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601899776?lang=zh_cn&edition=fundamental","pubTime":"2026-01-06 19:26","pubTimestamp":1767698803,"startTime":"0","endTime":"0","summary":"BUZZ-Apogee Therapeutics 因哮喘药物在早期试验中显示出前景而上涨1月6日 - ** 药物开发商Apogee Therapeutics APGE.O股价盘前上涨1.66%至78.35美元** 该公司称，其实验性药物zumilokibart在一项针对轻度至中度哮喘成人患者的早期试验中显示出强劲的疗效** Zumilokibart 可减少成人气道炎症 - AGPE** 公司称，单次用药后，疗效可持续32周；未发现严重副作用。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260106:nL4T3Y70OA:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["APGE","LU0053671581.USD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1160404547","title":"Apogee Therapeutics公布潜在同类最佳抗IL-13抗体Zumilokibart（APG777）治疗轻中度哮喘患者的1B期试验积极中期结果，并展望2026年里程碑与前景","url":"https://stock-news.laohu8.com/highlight/detail?id=1160404547","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1160404547?lang=zh_cn&edition=fundamental","pubTime":"2026-01-06 19:00","pubTimestamp":1767697219,"startTime":"0","endTime":"0","summary":"生物制药公司Apogee Therapeutics近日披露了其核心候选药物Zumilokibart（研发代号APG777）在轻中度哮喘患者中开展的1B期临床试验的中期分析数据，结果显示出积极信号。该抗体药物靶向IL-13通路，被公司定位为潜在“同类最佳”疗法。\n与此同时，Apogee还明确了2026年的关键研发节点与战略展望，为后续临床推进和商业化布局奠定基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0053671581.USD","BK4139","APGE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1132494108","title":"Apogee Therapeutics将于2026年1月6日召开电话会议 公布Apg777针对轻中度哮喘患者的1B期临床试验中期结果及2026年预期里程碑","url":"https://stock-news.laohu8.com/highlight/detail?id=1132494108","media":"美股速递","labels":["conferences","dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1132494108?lang=zh_cn&edition=fundamental","pubTime":"2026-01-06 05:03","pubTimestamp":1767646992,"startTime":"0","endTime":"0","summary":"Apogee Therapeutics宣布，公司计划于2026年1月6日举行专题电话会议，重点披露其候选药物Apg777在轻中度哮喘患者中开展的1B期临床试验的中期研究数据。此次会议还将详细阐述公司为2026年规划的关键发展节点与战略目标。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences,dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["APGE","BK4139","LU0053671581.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2592994944","title":"BUZZ-加拿大皇家银行称生物技术行业反弹势头强劲，2026 年商机无限","url":"https://stock-news.laohu8.com/highlight/detail?id=2592994944","media":"路透中文","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592994944?lang=zh_cn&edition=fundamental","pubTime":"2025-12-17 19:45","pubTimestamp":1765971927,"startTime":"0","endTime":"0","summary":"BUZZ-加拿大皇家银行称生物技术行业反弹势头强劲，2026 年商机无限12月17日 - ** 经纪公司 RBC Capital Markets 称，生物技术行业自 2025 年 4 月以来强劲反弹，得益于良好的临床数据和成功的新药上市，产生了更多盈利能力强、成熟的中市值公司。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251217:nL4T3XN0W4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["APOG","BK4585","LU0648001328.SGD","BK4135","LU0477156953.USD","LU0130517989.USD","BK4559","LU0053671581.USD","LU0130102774.USD","LU1201861249.SGD","APGE","BK4139","BK4588","XENE","LU0980610538.SGD","LU1699723380.USD","BK","BK4086","LU1571399168.USD","KYMR"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":19,"code":"91000000","status":"200"}]}}